Multiple sclerosis: Geoepidemiology, genetics and the environment
about
Oligodendrogenesis in the normal and pathological central nervous systemEvaluation of a multiple sclerosis cluster among nurses in an inpatient oncology wardImmunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysisImmunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysismiRNAs Participate in MS Pathological Processes and Its Therapeutic ResponseInnate Sensing of the Gut Microbiota: Modulation of Inflammatory and Autoimmune DiseasesExploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosisNew developments in the genetics, pathogenesis, and therapy of IgA nephropathyRole of apolipoprotein E in neurodegenerative diseasesSystematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosisEnvironmental risk factors for multiple sclerosis: a review with a focus on molecular mechanismsTreatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literatureMultiple sclerosis: molecular mechanisms and therapeutic opportunitiesLive Imaging of Immune Responses in Experimental Models of Multiple SclerosisEpidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel WorkshopPaucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK.Magnetic resonance imaging signatures of vascular pathology in multiple sclerosis.Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments.Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system.Distinguishing Susac's syndrome from multiple sclerosis.Indirect costs of absenteeism due to rheumatoid arthritis, psoriasis, multiple sclerosis, insulin-dependent diabetes mellitus, and ulcerative colitis in 2012: a study based on real-life data from the Social Insurance Institution in Poland.Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis.A comparison the effects of reflexology and relaxation on the psychological symptoms in women with multiple sclerosisPrevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients.Expression, regulation and function of microRNAs in multiple sclerosisAutoimmunity and environment: am I at risk?Ontogenetic de novo copy number variations (CNVs) as a source of genetic individuality: studies on two families with MZD twins for schizophrenia.Clinical and Epidemiological Aspects of Multiple Sclerosis in Children.Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.Extracranial venous stenosis is an unlikely cause of multiple sclerosis.Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis.Susceptibility Genes for Multiple Sclerosis Identified in a Gene-Based Genome-Wide Association StudyPain is associated with prospective memory dysfunction in multiple sclerosis.Gut microbiome and the risk factors in central nervous system autoimmunity.Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health.Discovery and biological characterization of two novel pig-tailed macaque homologs of HHV-6 and HHV-7.Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines?Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic reviewEffect of a self-management and follow-up program on self-efficacy in patients with multiple sclerosis: a randomized clinical trialMultiple sclerosis: pathogenesis and treatment.
P2860
Q21129352-12846AEF-08B2-4B6C-828F-60511A43E7EBQ23912471-E172416B-3584-41C3-B2D0-DBB24DF573F8Q24202108-86BF2A15-0323-4307-8B20-6DDA5D474DF4Q24235249-2DE09887-0C13-426F-8784-59112AE18ED9Q26748774-941AB593-C37B-4F0D-8F16-3641292F420EQ26765847-FCEC29D6-8150-4002-9A5D-AD13546B58EBQ26770818-B1C9FE07-DBEC-42CA-966A-F1C913BC0C8CQ26786248-504034A6-4DB4-4FA5-B13C-732400FD1BEFQ26799413-25A39142-D19E-4277-B45C-CA21DD8AC5F1Q26852295-52BE9CA6-96A6-4CA2-9AEC-CE3E75E261ADQ27006548-1AB2A002-6062-4089-B29A-35D1F3DD975DQ27015089-E3F6722F-D0C4-40C2-8202-0A95AA8A982FQ27023735-ED12C60A-CF64-46C0-B95C-2C1C56CB78E6Q28075478-83544CEE-F6B6-4C91-BA9A-B30D428F6D83Q28390922-D99D4CB4-EE8E-4898-A0AA-12BAAC8D1F12Q30387509-1093F2D7-6AFF-4348-8A98-3B465721BD8EQ30564477-57221B4C-2080-4CA4-8A25-4C3CD56B7273Q30651607-8D69A8CE-8485-4635-8C08-6D46AB5C0E5AQ30850488-FC25DEF9-74F4-486A-A0F5-C0FFB868C0C3Q30882185-BCFAF55B-DB08-4DF1-902A-97DCD82EBBB2Q30993921-FB5AEA61-EEE6-4BDD-8B0D-988770162BE4Q33638157-5AC75633-3069-4B1A-9AE9-BF7BC2D6B592Q33693447-FA484C20-7213-4FE7-B31E-D06E342443A7Q33712335-10584536-8DB8-495B-9176-0A1B02EE7C1AQ33754662-530EF19E-ED92-4C64-B917-3E272DA8CE58Q33825348-414799F7-E90B-448D-B5EF-06D3B0540217Q33844724-A93722D9-A21F-4700-B2A3-DE431FA8BC4AQ33861610-10A49BFE-BC5B-4A8A-8F97-5DA005CA59A7Q34034063-D2FFDCAE-9FF7-481A-A774-1D1C107952D6Q34147397-39699CAA-D8BE-4BC9-8B61-9559F55A7DADQ34318250-A9D81404-9061-4833-863E-79F9EAAABDAAQ34491571-F1BD7630-4CB7-464C-8FE8-B28F97512709Q34498665-4937939C-6CCC-45B5-AF88-21BAE353764FQ34624054-C2BAA1A2-A461-4E68-83A2-1B97B94F508AQ35024885-7357C2C7-6267-45B4-95FE-1C6DDC1FED6EQ35032589-78D3CB03-4EF4-4F3A-B4B5-803C985A0A6EQ35036908-E097E388-7B5D-422D-AB78-C7D7DEEF69E4Q35087429-1ADF717B-C61A-44EA-A4B3-DF1FD072EDC6Q35144595-CBF5F4E9-2A49-4E25-83E8-126C7CF8F8BEQ35151851-3368E9B5-CDB6-47F6-8BEA-EA28830D2448
P2860
Multiple sclerosis: Geoepidemiology, genetics and the environment
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Multiple sclerosis: Geoepidemiology, genetics and the environment
@ast
Multiple sclerosis: Geoepidemiology, genetics and the environment
@en
Multiple sclerosis: Geoepidemiology, genetics and the environment
@en-gb
Multiple sclerosis: Geoepidemiology, genetics and the environment
@nl
type
label
Multiple sclerosis: Geoepidemiology, genetics and the environment
@ast
Multiple sclerosis: Geoepidemiology, genetics and the environment
@en
Multiple sclerosis: Geoepidemiology, genetics and the environment
@en-gb
Multiple sclerosis: Geoepidemiology, genetics and the environment
@nl
altLabel
Multiple sclerosis: geoepidemiology, genetics and the environment
@en
prefLabel
Multiple sclerosis: Geoepidemiology, genetics and the environment
@ast
Multiple sclerosis: Geoepidemiology, genetics and the environment
@en
Multiple sclerosis: Geoepidemiology, genetics and the environment
@en-gb
Multiple sclerosis: Geoepidemiology, genetics and the environment
@nl
P3181
P1433
P1476
Multiple sclerosis: Geoepidemiology, genetics and the environment
@en
P2093
Esther Kahana
P304
P3181
P356
10.1016/J.AUTREV.2009.11.010
P407
P50
P577
2010-03-01T00:00:00Z